BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
Business/Source-attributed reporting

Dr Reddy’s launches two new semaglutide brands amid Obeda supply disruptions

The drugmaker has shifted production to a partner facility and expects to resolve the impurity issue affecting its injectable product next month.

The drugmaker has shifted production to a partner facility and expects to resolve the impurity issue affecting its injectable product next month.
ORIGINAL SOURCE

Business Line - Home

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗